SGRY 241220 35.00C (SGRY241220C35000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

SGRY241220C35000

Watchlist

0.05
-0.35-87.50%

15min DelayClose Dec 13 15:59 ET

0.05High0.05Low

Intraday

5D
Daily

News

JPMorgan Adjusts Surgery Partners Price Target to $28 From $38, Maintains Neutral Rating
MT NewswiresDec 3 07:35 ET · Ratings
Surgery Partners, Inc. (NASDAQ:SGRY) Is Expected To Breakeven In The Near Future
Simply Wall StNov 29 05:53 ET
Key Takeaways From Surgery Partners Analyst Ratings
BenzingaNov 20 12:00 ET · Ratings
Surgery Partners Is Maintained at Outperform by RBC Capital
Dow JonesNov 20 11:27 ET · Ratings
RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Cuts Target Price to $35
Moomoo NewsNov 20 09:31 ET · Ratings
Express News | Surgery Partners Inc : RBC Cuts Target Price to $35 From $49
ReutersNov 20 01:44 ET

Comments

Moomoo AI

Mar 27 05:54

Surgery Partners' historical ROCE trend doesn't indicate potential for future multi-bagger status. Persistent low return on capital from its investments makes it unlikely to be a multi-bagger.

Returns On Capital At Surgery Partners (NASDAQ:SGRY) Have Hit The Brakes

Moomoo AI

Feb 2 06:10

Surgery Partners' high P/S ratio, despite industry-standard revenue forecasts, could risk shareholders' investments and potential investors may pay an unnecessary premium. This may be due to bullish sentiment, which could lead to disappointment if the P/S falls in line with the growth outlook.

Investor Optimism Abounds Surgery Partners, Inc. (NASDAQ:SGRY) But Growth Is Lacking

Moomoo AI

Nov 17, 2023 05:01

Given Surgery Partners' current ROCE trends, it is not seen as a potential high-yield investment. Despite the stock's impressive performance in past years, if current underlying trends continue, the odds of it being a multi-bagger from here is slim.

Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement

Analysts Notebook

Jun 15, 2022 06:04

Columns Top upgrades and downgrades on 6/15: SPOT, SNOW, CLR, CMTL and more

Upgrades
• $Arcos Dorados (ARCO.US)$ : Bradesco BBI Upgrades to Outperform from Neutral - PT $12
• $Armstrong World Industries (AWI.US)$ : Loop Capital Upgrades to Buy from Hold - PT $95
• $Cullen/Frost Bankers (CFR.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $155 (from $143)
• $Digital Realty Trust Inc (DLR.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $144 (from $150)
• $Liberty Formula One-A (FWONA.US)$ : Mor...